Skoči na glavni sadržaj

Izlaganje sa skupa

PSYCHOPHARMACOTHERAPY PRESCRIPTION AND SUICIDAL BEHAVIOUR

Helena Korosec Jagodic ; Psychiatric Hospital Vojnik, Vojnik, Slovenia
Mark Agius ; South Essex Partnership University Foundation Trust, Weller Wing, Bedford Hospital, Bedford, UK ; Department of Psychiatry University of Cambridge, UK ; Clare College Cambridge, Cambridge, UK
Peter Pregelj ; University Psychiatric Hospital Ljubljana, Ljubljana, Slovenia ; University of Ljubljana, Faculty of Medicine, Department of Psychiatry, Ljubljana, Slovenia


Puni tekst: engleski pdf 70 Kb

str. 324-328

preuzimanja: 136

citiraj


Sažetak

Suicidal behaviour has multiple causes. Psychiatric disorder is a major contributing factor. Consecutively, diagnosis and
treatment of mental disorders has an impact on suicide rate. The studies that investigated the possible impact of psychopharmacotherapy
prescription practise on suicide rate have been gathered in the present article. Ongoing discussion of potential
benefits and risks of antidepressant treatment with respect to suicidal behaviours includes many ecological, or population- based,
correlational studies of temporal or regional trends in suicide rates and rates of usage of modern antidepressants including SSRIs. A
number of studies have found a relationship between increase in national antidepressant prescribing and declining suicide rates,
with general agreement but some exceptions. In general, studies showed that increased prescribing of antidepressants may indicate
improved diagnosis and treatment of depression. On the other hand, studies that investigated the impact of prescription of anxyolitics
on suicide rate were scarce, although the ratio of anxiolytics to antidepressants has been described as a quality indicator regarding
treatment of depression, which is in most cases combined with anxiety and increased suicide risk. Importantly, sedatives and
hypnotics are widely prescribed to elderly persons with symptoms of depression, anxiety, and sleep disturbance, but studies
demonstrated that sedatives and hypnotics were both associated with increased risk for suicide in the elderly. Finally, studies on
antipsychotic prescription demonstrated that particularly treatment with clozapine decreased suicide mortality among individuals
with schizophrenia and schizoaffective disorders and on the other hand lithium reduced suicide rate among individuals with mood
disorders.

Ključne riječi

suicide rate; antidepressants; anxiolytics; antipsychotics; depression

Hrčak ID:

266700

URI

https://hrcak.srce.hr/266700

Datum izdavanja:

26.8.2013.

Posjeta: 352 *